IRIS
FERRARI, GIULIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.955
AS - Asia 1.681
NA - Nord America 1.195
SA - Sud America 319
AF - Africa 38
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 5.195
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 1.326
US - Stati Uniti d'America 1.131
SG - Singapore 648
CN - Cina 505
BR - Brasile 252
HK - Hong Kong 187
IT - Italia 177
VN - Vietnam 146
FR - Francia 104
SE - Svezia 80
TR - Turchia 57
DE - Germania 55
GB - Regno Unito 51
FI - Finlandia 34
CA - Canada 31
BD - Bangladesh 30
NL - Olanda 30
IN - India 28
AR - Argentina 26
MX - Messico 22
IE - Irlanda 17
ZA - Sudafrica 17
ES - Italia 14
AT - Austria 11
EC - Ecuador 11
JP - Giappone 11
CH - Svizzera 9
IQ - Iraq 9
PK - Pakistan 9
PL - Polonia 9
CL - Cile 8
CO - Colombia 8
BG - Bulgaria 7
BE - Belgio 6
MA - Marocco 6
AE - Emirati Arabi Uniti 5
LT - Lituania 5
PH - Filippine 5
PY - Paraguay 5
RO - Romania 5
SA - Arabia Saudita 5
UA - Ucraina 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
ID - Indonesia 4
TN - Tunisia 4
VE - Venezuela 4
DO - Repubblica Dominicana 3
EG - Egitto 3
EU - Europa 3
IL - Israele 3
IR - Iran 3
JO - Giordania 3
KG - Kirghizistan 3
MY - Malesia 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
CU - Cuba 2
DZ - Algeria 2
HN - Honduras 2
JM - Giamaica 2
KR - Corea 2
PE - Perù 2
PS - Palestinian Territory 2
SN - Senegal 2
UY - Uruguay 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
KE - Kenya 1
KZ - Kazakistan 1
MD - Moldavia 1
MR - Mauritania 1
OM - Oman 1
PT - Portogallo 1
RS - Serbia 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.195
Salva come PNG Salva come JPEG
Città #
Singapore 301
Moscow 293
Ashburn 207
Hong Kong 177
San Jose 157
Dallas 148
Shanghai 79
Lauterbourg 77
Milan 69
Hefei 68
Beijing 65
Ho Chi Minh City 62
New York 50
Istanbul 49
Hanoi 38
Lawrence 37
Los Angeles 37
Princeton 37
Amsterdam 24
Helsinki 21
Rio de Janeiro 20
Rome 19
Xi'an 19
Orem 18
Council Bluffs 17
Dublin 17
Brooklyn 16
São Paulo 16
Chicago 15
London 15
Santa Clara 14
Chennai 12
Boston 11
Guangzhou 11
Nuremberg 11
Porto Alegre 11
Johannesburg 10
Poplar 10
Tokyo 10
Atlanta 9
Munich 9
Stockholm 9
Warsaw 9
Boardman 8
Houston 8
Mexico City 8
Montreal 8
Paris 7
Quito 7
Falkenstein 6
Frankfurt am Main 6
Lappeenranta 6
Phoenix 6
San Francisco 6
Turku 6
Washington 6
Ankara 5
Baghdad 5
Catania 5
Cesano Boscone 5
Charlotte 5
Denver 5
Hải Dương 5
Manchester 5
Shenzhen 5
Silistra 5
Toronto 5
Vienna 5
Yverdon-les-Bains 5
Bauru 4
Belo Horizonte 4
Bologna 4
Brasília 4
Brussels 4
Buffalo 4
Dhaka 4
Jeddah 4
Karachi 4
Mauá 4
Miami 4
Mumbai 4
Ottawa 4
Tashkent 4
Amman 3
Asunción 3
Auckland 3
Bengaluru 3
Bishkek 3
Borås 3
Brescia 3
Calgary 3
Campinas 3
Caracas 3
Changchun 3
Concord 3
Elche 3
Florence 3
Fortaleza 3
Gravataí 3
Haiphong 3
Totale 2.564
Salva come PNG Salva come JPEG
Nome #
Beauveria bassiana Keratitis: A Case Series and Review of Literature 161
An innovative platform approach for the development of ex-vivo gene therapies for the treatment of lysosomal storage diseases with skeletal involvement 118
Anterior segment involvement in vitreoretinal lymphoma: Clinical manifestations, molecular findings and in vivo confocal microscopy 108
Angiopoietin 2 expression in the cornea and its control of corneal neovascularisation 105
Corneal and Epidermal Nerve Quantification in Chemotherapy Induced Peripheral Neuropathy 98
Alkali burn versus suture-induced corneal neovascularization in C57BL/6 mice: An overview of two common animal models of corneal neovascularization 96
A hypothalamic-controlled neural reflex promotes corneal inflammation 96
The Effects of Vitamin D on Keratoconus Progression 93
Aprepitant Restores Corneal Sensitivity and Reduces Pain in DED 90
Future directions in managing aniridia-associated keratopathy 89
Topical fosaprepitant for the treatment of ocular pain and inflammation 86
VesselJ: a new tool for automatic measurement of corneal neovascularization ex-vivo 85
Vitamin D Supplementation Impacts Systemic Biomarkers of Collagen Degradation and Copper Metabolism in Patients With Keratoconus 83
Ribavirin Aerosol in the Treatment of SARS-CoV-2: A Case Series 83
Corneal collagen cross-linking in paediatric patients affected by keratoconus 80
Symptoms and signs of conjunctivitis as predictors of disease course in COVID-19 syndrome 79
Topical formulations of Aprepitant are safe and effective in relieving pain and inflammation, and drive neural regeneration 76
Neurosensory abnormalities and stability of a mouse model of dry eye disease 76
Corneal Angiogenesis, Sensitivity, and Visual Acuity: a Retrospective Study 76
Safety and Efficacy of Corneal Cross-Linking in Patients Affected by Keratoconus: Long-Term Results 75
Corneal collagen crosslinking and herpetic keratitis Reply 74
A Novel Mouse Model of Acute Ocular Graft-versus-Host Disease 73
Corneal endothelial cell reduction and increased Neurokinin-1 receptor expression in a graft-versus-host disease preclinical model 72
The keratoconus enigma: A review with emphasis on pathogenesis 72
Corneal collagen cross-linking for management of keratoconus in patients affected by Tourette syndrome 71
Corneal confocal microscopy reveals trigeminal small sensory fiber neuropathy in amyotrophic lateral sclerosis 70
Double-biguanide therapy for resistant acanthamoeba keratitis 68
Epidemiology of Corneal Neovascularization and Its Impact on Visual Acuity and Sensitivity: A 14-Year Retrospective Study 67
Future directions in managing aniridia-associated keratopathy 66
Corneal neovascularization and its potential biomarkers in human tears 65
Cultivated limbal epithelial transplantation 65
The role of extracellular matrix in mouse and human corneal neovascularization 64
Erratum: The Effect of Aging on Nerve Morphology and Substance P Expression in Mouse and Human Corneas (Invest Ophthalmol Vis Sci., (2018) 59, (5329-5335), 10.1167/iovs.18-24707) 63
High Frequency Electrotherapy for the Treatment of Meibomian Gland Dysfunction 62
Trigeminal stereotactic electrolysis induces dry eye in mice 61
Trigeminal stereotactic electrolysis induces dry eye in mice 61
Modulating ocular surface pain through neurokinin-1 receptor blockade 61
Targeting amyloid-β in glaucoma treatment 61
Nutritional and Metabolic Imbalance in Keratoconus 60
Substance P aggravates corneal epithelial stem cell deficiency 60
Substance P/neurokinin-1 receptor pathway blockade ameliorates limbal stem cell deficiency by modulating mTOR pathway and preventing cell senescence 59
The two-faced effects of nerves and neuropeptides in corneal diseases 58
Quantifying Ocular Surface Inflammation and Correlating It With Inflammatory Cell Infiltration In Vivo: A Novel Method 58
Innovative high-frequency electrotherapy device Rexon-Eye successfully treats Meibomian gland disease patients 57
Corrigendum to "Corneal innervation as a window to peripheral neuropathies" [Exp. Eye Res. 113 (2013) 148-150] DOI: 10.1016/j.exer.2013.05.016 57
In vivo confocal microscopy in goldenhar syndrome: a case report 57
Topically Applied Neurokinin-1 Receptor Antagonists to Treat Ocular Surface Inflammation 56
Substance P and its Inhibition in Ocular Inflammation 56
Corneal confocal microscopy in non-length-dependent small fiber neuropathy 55
Managing the ocular surface after glaucoma filtration surgery: an orphan topic 55
TFOS Lifestyle: Impact of lifestyle challenges on the ocular surface 54
IN VIVO CORNEAL CONFOCAL MICROSCOPY IN PATIENTS WITH GUILLAIN-BARRE SYNDROME 53
Substance p modulation of human and murine corneal neovascularization 51
Evaluation of a Post-Operative Therapy Protocol after Epithelium-Off Corneal Cross-Linking in Patients Affected by Keratoconus 50
Topical ranibizumab as a treatment of corneal neovascularization 50
NK1 Receptor Antagonists as a New Treatment for Corneal Neovascularization 50
Innovative radiofrequency electrotherapy significantly reduces cornea perforation in an alkali burn murine model 49
Nerves in the cornea: proper functioning and healing potential 49
Immunity and pain in the eye: focus on the ocular surface 48
Modulating the tachykinin: Role of substance P and neurokinin receptor expression in ocular surface disorders 48
Keratoconus: The Local Manifestation of a Systemic Disease? 48
TFOS lifestyle: Impact of lifestyle challenges on the ocular surface 48
Tie2-gfp transgenic mouse as a new model to study corneal neovascularization 47
Reciprocal Inhibition of Nerves and Neovessels in the Cornea 47
Impending corneal perforation after collagen cross-linking for herpetic keratitis 47
Growth inhibition of formed corneal neovascularization following Fosaprepitant treatment 46
VesselJ: A New Tool for Semiautomatic Measurement of Corneal Neovascularization 46
Safety and Efficacy of Topical Infliximab in a Mouse Model of Ocular Surface Scarring 46
Topical neurokinin-1 receptor antagonist Fosaprepitant ameliorates ocular graft-versus-host disease in a preclinical mouse model 46
Tumor Necrosis Factor-alpha Inhibitors as a Treatment of Corneal Hemangiogenesis and Lymphangiogenesis 45
Topical application of infliximab (Remicade®) in the treatment of corneal caustication 43
Ocular Surface Injury Induces Inflammation in the Brain: In Vivo and Ex Vivo Evidence of a Corneal-Trigeminal Axis 41
Cell therapy in the cornea: The emerging role of microenvironment 40
In vivo evaluation of DSAEK interface with scanning-laser confocal microscopy 40
Topical formulations of aprepitant are safe and effective in relieving pain and inflammation, and drive neural regeneration 39
Congenital aniridia: European COST action ANIRIDIA-NET guidelines for diagnosis, management and care 36
Managing the ocular surface after glaucoma filtration surgery: an orphan topic (Graefe's Archive for Clinical and Experimental Ophthalmology, (2024), 262, 7, (2039-2056), 10.1007/s00417-023-06333-5) 35
A novel mouse model for neurotrophic keratopathy: Trigeminal nerve stereotactic electrolysis through the brain 33
Bitot's spot in vitamin a deficiency 28
Corneal neovascularization and the utility of topical VEGF inhibition: Ranibizumab (Lucentis) Vs bevacizumab (Avastin) 25
Chemotherapy-associated peripheral sensory neuropathy assessed using in vivo corneal confocal microscopy 25
Trans-scleral delivery of macromolecules 24
Corneal innervation as a window to peripheral neuropathies 23
Short-term topical bevacizumab in the treatment of stable corneal neovascularization 23
Porcine sclera as a model of human sclera for in vitro transport experiments: histology, SEM, and comparative permeability 23
In vitro transscleral iontophoresis of high molecular weight neutral compounds 23
Topical interleukin 1 receptor antagonist for treatment of dry eye disease: A randomized clinical trial 23
Ex vivo models to evaluate the role of ocular melanin in trans-scleral drug delivery 21
Dependence of corneal stem/progenitor cells on ocular surface innervation 19
Laser scanning in vivo confocal microscopy in a case of terrien marginal degeneration 19
Reply 18
In-vitro permeation of bevacizumab through human sclera: Effect of iontophoresis application 16
Nerves and neovessels inhibit each other in the cornea 15
Non-length-dependent small fibre neuropathy. Confocal microscopy study of the corneal innervation 13
The Impact of Aging and Sex on Corneal Nerve Density and Function 6
The NK-1 Receptor Signaling: Distribution and Functional Relevance in the Eye 2
The Role of Innervation in Ocular Surface Homeostasis, Tissue Remodeling Following Nerve Injury, and the Therapeutic Potential of Hemocomponents in Neuronal and Cicatricial Pathologies † 1
Totale 5.359
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.655
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.655
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202228 0 0 0 7 0 2 0 7 4 7 0 1
2022/2023215 90 31 10 2 1 13 17 6 6 0 32 7
2023/2024225 0 7 32 43 23 31 8 19 2 10 41 9
2024/20251.004 135 30 17 27 71 62 167 98 168 59 98 72
2025/20263.869 227 262 157 398 544 91 385 304 1.214 207 80 0
Totale 5.359